This website uses cookies

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. We also share information about your use of our site with our social media, advertising and analytics partners who may combine it with other information that you’ve provided to them or that they’ve collected from your use of their services.

Coronex small


Coronex is a collaboration of Scottish and UK based biotechnology industry partners working with NHS Greater Glasgow and Clyde clinical and biorepository teams on the development of highly optimised lateral flow tests. Whilst primary focus has been on SARS-CoV-2, the same core technology has applications for other infectious agents, and may also be used for monitoring therapeutic antibodies used as drug treatments or in detecting auto-antibodies in autoimmune disorders.

Coronex is a 2020 spin-out company of NHS Greater Glasgow and Clyde and InnoScot Health.